Altimmune, Inc. (ALT)
NASDAQ: ALT · Real-Time Price · USD
3.710
-0.070 (-1.85%)
At close: Sep 8, 2025, 4:00 PM
3.730
+0.020 (0.54%)
After-hours: Sep 8, 2025, 4:32 PM EDT
Altimmune Market Cap
Altimmune has a market cap or net worth of $327.43 million as of September 8, 2025. Its market cap has decreased by -35.38% in one year.
Market Cap
327.43M
Enterprise Value
163.71M
1-Year Change
-35.38%
Ranking
Category
Stock Price
$3.71
Market Cap Chart
Since October 6, 2005, Altimmune's market cap has increased from $81.50M to $327.43M, an increase of 301.76%. That is a compound annual growth rate of 7.23%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Sep 5, 2025 | 333.60M | -34.95% |
Dec 31, 2024 | 512.80M | -15.16% |
Dec 29, 2023 | 604.40M | -25.26% |
Dec 30, 2022 | 808.70M | 122.17% |
Dec 31, 2021 | 364.00M | -2.41% |
Dec 31, 2020 | 373.00M | 1,186.21% |
Dec 31, 2019 | 29.00M | 61.11% |
Dec 31, 2018 | 18.00M | -42.12% |
Dec 29, 2017 | 31.10M | -85.66% |
Dec 30, 2016 | 216.90M | 77.06% |
Dec 31, 2015 | 122.50M | 6.80% |
Dec 31, 2014 | 114.70M | 17.88% |
Dec 31, 2013 | 97.30M | 79.52% |
Dec 31, 2012 | 54.20M | -11.58% |
Dec 30, 2011 | 61.30M | -64.57% |
Dec 31, 2010 | 173.00M | 210.59% |
Dec 31, 2009 | 55.70M | -6.39% |
Dec 31, 2008 | 59.50M | -31.77% |
Dec 31, 2007 | 87.20M | 1.04% |
Dec 29, 2006 | 86.30M | 4.10% |
Dec 30, 2005 | 82.90M | 1.72% |
Oct 6, 2005 | 81.50M | - |
View and export this data all the way back to 2005. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 652.84B |
Johnson & Johnson | 429.72B |
AbbVie | 375.50B |
UnitedHealth Group | 285.64B |
AstraZeneca | 253.68B |
Novartis AG | 252.55B |
Novo Nordisk | 244.67B |
Abbott Laboratories | 231.38B |